St. John's Wort Depression Claim Draws FDA "Courtesy" Letter
This article was originally published in The Tan Sheet
Executive Summary
The labeling statement that St. John's wort "has been confirmed to possess emotionally supportive properties in those individuals who are feeling mildly depressed" constitutes an unapproved new drug claim, FDA told Henderson, Nev.-based The Winning Combination in a Sept. 9 "courtesy" letter.